PTC Inc
PTC
193.60
+0.60
+0.31%
PTC Inc
US · PTC
#1117 by market cap
Listed 1970
193.60
+0.60
+0.31%
Live - 5344 symbols - heartbeat 196s ago
· 2026-10-08 08:04
Pre-market
193.49
-0.06%
After-hours
193.60
0.00%
Overnight
193.60
0.00%
- Market cap
- 21.01B
- P/E (TTM)i
- 18.78
- P/Bi
- 6.05
- EPSi
- 6.08
- Div yieldi
- 0.00%
- 52W posi
- 87%
Reader sentiment
Are you bullish or bearish on PTC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.90, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +19.18% YoY
Margins
- Gross margin
- 83.76%
- Operating margin
- 36.43%
- Net margin
- 26.80%
Key ratios & quality
- Enterprise valuei
- 22.04B
- PEG ratioi
- 0.57
- Altman Z-Scorei
- 5.90
PEG uses trailing P/E against the 3-year net income growth rate (32.85%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.24B | 1.26B | 1.46B | 1.81B | 1.93B | 2.10B | 2.30B | 2.74B |
| Gross profit | 915.32M | 930.25M | 1.12B | 1.44B | 1.55B | 1.66B | 1.85B | 2.29B |
| Selling & admin expenses | 557.81M | 545.37M | 595.28M | 723.79M | 689.98M | 763.64M | 791.33M | 792.57M |
| Research & development | 249.79M | 246.89M | 256.58M | 299.92M | 338.82M | 394.37M | 433.05M | 457.69M |
| Operating profit | 76.38M | 114.16M | 243.58M | 382.96M | 483.60M | 458.01M | 587.26M | 998.03M |
| Pretax profit | 28.66M | 20.30M | 134.71M | 391.76M | 397.10M | 332.57M | 468.96M | 920.18M |
| Tax | -23.33M | 47.76M | 4.01M | -85.17M | 84.02M | 87.03M | 92.63M | 186.18M |
| Net profit | 51.99M | -27.46M | 130.70M | 476.92M | 313.08M | 245.54M | 376.33M | 734.00M |
| Basic EPS | 0 | 0 | 1 | 4 | 3 | 2 | 3 | 6 |
| Diluted EPS | 0.44 | -0.23 | 1.12 | 4.03 | 2.65 | 2.06 | 3.12 | 6.08 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 636.37M | 643.94M | 893.80M | 685.83M | 774.30M | 600.05M |
| Gross profit | 530.10M | 533.91M | 776.90M | 568.08M | 660.69M | 490.47M |
| Selling & admin expenses | 180.02M | 195.90M | 205.80M | 214.89M | 228.74M | 196.26M |
| Research & development | 111.02M | 116.65M | 114.51M | 119.98M | 124.13M | 115.71M |
| Operating profit | 227.68M | 209.83M | 445.00M | 221.13M | 295.80M | 166.51M |
| Pretax profit | 205.25M | 193.68M | 428.10M | 202.98M | 746.80M | 152.44M |
| Tax | 42.61M | 52.35M | 80.31M | 36.46M | 156.08M | 33.66M |
| Net profit | 162.64M | 141.33M | 347.79M | 166.52M | 590.72M | 118.78M |
| Basic EPS | 1 | 1 | 3 | 1 | 5 | 1 |
| Diluted EPS | 1.35 | 1.17 | 2.94 | 1.39 | 4.98 | 1.03 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 633.78M | 782.62M | 833.45M | 1.07B | 1.07B | 1.28B | 1.30B | 1.38B |
| Cash & ST investments | 285.78M | 297.47M | 303.59M | 326.53M | 272.18M | 288.10M | 265.81M | 184.42M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 2.33B | 2.66B | 3.38B | 4.51B | 4.69B | 6.29B | 6.38B | 6.62B |
| Total current liabilities | 735.28M | 638.16M | 680.76M | 779.28M | 792.26M | 1.67B | 1.67B | 1.24B |
| Short-term debt | -- | -- | 34.64M | 27.86M | 22.00M | 34.11M | 545.69M | 49.18M |
| Long-term debt | 643.27M | 669.13M | 1.01B | 1.44B | 1.35B | 1.69B | 1.23B | 1.17B |
| Total liabilities | 1,454,433,000.00 | 1,462,590,000.00 | 1,944,490,000.00 | 2,469,092,000.00 | 2,391,234,000.00 | 3,611,552,000.00 | 3,169,144,000.00 | 2,790,943,000.00 |
| Total equity | 874.59M | 1.20B | 1.44B | 2.04B | 2.30B | 2.68B | 3.21B | 3.83B |
| Retained earnings | -599.41M | -191.39M | -62.27M | 414.66M | 727.74M | 973.28M | 1.35B | 2.08B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.13B | 1.09B | 1.38B | 1.39B | 1.50B | 1.37B |
| Cash & ST investments | 235.17M | 199.32M | 184.42M | 209.74M | 439.11M | 351.45M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 6.16B | 6.23B | 6.62B | 6.43B | 6.54B | 6.51B |
| Total current liabilities | 1.15B | 1.23B | 1.24B | 1.14B | 1.22B | 1.34B |
| Short-term debt | 49.32M | 50.11M | 49.18M | 48.24M | 47.80M | 49.14M |
| Long-term debt | 1.36B | 1.21B | 1.17B | 1.17B | 1.17B | 1.40B |
| Total liabilities | 2,775,968,000.00 | 2,716,170,000.00 | 2,790,943,000.00 | 2,584,844,000.00 | 2,677,387,000.00 | 3,043,834,000.00 |
| Total equity | 3.39B | 3.51B | 3.83B | 3.84B | 3.86B | 3.47B |
| Retained earnings | 1.59B | 1.74B | 2.08B | 2.25B | 2.84B | 2.96B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 247.75M | 285.15M | 233.81M | 368.81M | 435.33M | 610.86M | 749.98M | 867.70M |
| Depreciation & amortization | 87.41M | 77.82M | 119.50M | 122.53M | 122.04M | 137.16M | 141.41M | 135.42M |
| Free cash flow | 208.71M | 220.73M | 202.56M | 343.55M | 409.38M | 587.05M | 735.61M | 856.69M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -84.35M | -102.02M | 18.38M | -8.43M | -103.79M | 21.65M | 25.67M | -273.94M |
| Ending cash balance | 261.09M | 270.69M | 275.96M | 327.05M | 272.89M | 288.80M | 266.47M | 184.99M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 281.31M | 243.93M | 104.03M | 269.75M | 320.92M | 260.63M |
| Depreciation & amortization | 33.68M | 33.83M | 34.15M | 34.13M | 33.59M | 32.19M |
| Free cash flow | 278.50M | 242.04M | 100.48M | 267.40M | 318.25M | 249.35M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -61.69M | -74.99M | -62.26M | -200.03M | -612.96M | -500.03M |
| Ending cash balance | 235.74M | 199.89M | 184.99M | 210.31M | 439.69M | 352.03M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 5.91 | -2.64 | 9.90 | 27.44 | 14.45 | 9.87 | 12.78 | 20.85 |
| ROA %i | 2.22 | -1.10 | 4.32 | 12.09 | 6.81 | 4.47 | 5.94 | 11.29 |
| ROIC %i | 5.11 | 0.06 | 8.98 | 16.15 | 9.41 | 8.03 | 9.65 | 15.34 |
| 5-year avg ROE %i | 4.76 | 0.63 | 1.50 | 8.26 | 11.01 | 11.80 | 14.89 | 17.08 |
| EBIT margin %i | 5.66 | 5.05 | 14.48 | 24.47 | 23.35 | 22.03 | 25.61 | 36.40 |
| FCF / sales %i | 16.81 | 17.58 | 13.89 | 19.01 | 21.17 | 27.96 | 31.83 | 31.27 |
| Current ratioi | 0.86 | 1.23 | 1.22 | 1.38 | 1.35 | 0.76 | 0.78 | 1.12 |
| Quick ratioi | 0.56 | 1.05 | 1.06 | 1.11 | 1.15 | 0.66 | 0.68 | 0.96 |
| Debt / assetsi | 27.62 | 25.11 | 36.08 | 36.57 | 32.86 | 30.04 | 30.24 | 20.70 |
| LT debt / equityi | 73.55 | 55.67 | 82.44 | 79.49 | 66.12 | 69.28 | 43.08 | 34.52 |
| Interest coveragei | 1.69 | 1.47 | 2.76 | 8.76 | 8.32 | 3.57 | 4.92 | 12.95 |
| Revenue CAGR (3Y) %i | -0.36 | 3.26 | 7.80 | 13.32 | 15.47 | 12.87 | 8.35 | 12.32 |
| Net income CAGR (3Y) %i | 3.01 | -- | 175.66 | 109.34 | -- | 23.39 | -7.59 | 32.85 |
| FCF CAGR (3Y) %i | 11.82 | 12.01 | 22.66 | 18.07 | 22.86 | 42.57 | 28.89 | 27.91 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 13.91 | 15.71 | 20.85 | 23.14 | 34.40 | 35.05 |
| ROA %i | 7.12 | 8.30 | 11.29 | 13.09 | 19.63 | 19.21 |
| ROIC %i | 10.21 | 11.65 | 15.34 | 17.22 | 25.45 | 25.44 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 26.86 | 30.23 | 36.40 | 38.54 | 54.69 | 54.02 |
| FCF / sales %i | 34.77 | 34.22 | 31.27 | 31.06 | 30.96 | 31.67 |
| Current ratioi | 0.99 | 0.89 | 1.12 | 1.22 | 1.23 | 1.03 |
| Quick ratioi | 0.83 | 0.74 | 0.96 | 0.89 | 1.06 | 0.88 |
| Debt / assetsi | 25.44 | 22.66 | 20.70 | 21.49 | 21.13 | 24.68 |
| LT debt / equityi | 44.83 | 38.76 | 34.52 | 34.69 | 34.54 | 44.92 |
| Interest coveragei | 6.68 | 8.79 | 12.95 | 15.26 | 24.13 | 24.43 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Product lifecycle management (PLM) is the largest reported line at 59.49% of revenue, across 2 reported segments.
- Computer-aided design (CAD) follows at 40.51%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Product lifecycle management (PLM)59.49%
Computer-aided design (CAD)40.51%
Quote time 2026-10-08 08:04:54 · For reference only, not investment advice and not tailored to your situation.